
By Jessica Eve (Java, Indonesia)

REFERENCES
- Winchester DE, Mehta JJ, Alexander JT. Perioperative cardiovascular medication
management for noncardiac surgery. JAMA. Published online March 31, 2026.
doi:10.1001/jama.2026.0067 - American Heart Association. 2024 AHA/ACC guideline for perioperative cardiovascular
evaluation and management of patients undergoing noncardiac surgery. Circulation.
2024;150:e351–e442. doi:10.1161/CIR.0000000000001285 - Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Alonso-Coello P, Kurz A, et al;
POISE-2 Investigators. Aspirin in patients undergoing noncardiac surgery. N Engl J Med.
2014;370(16):1494–1503. doi:10.1056/NEJMoa1401105 - Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, et al; POISE Study
Group. Effects of extended-release metoprolol succinate in patients undergoing non-
cardiac surgery (POISE trial): a randomised controlled trial. Lancet.
2008;371(9627):1839–1847. doi:10.1016/S0140-6736(08)60601-7 - Neumann A, Maura G, Weill A, Alla F, Danchin N. Clinical events after discontinuation of
β-blockers in patients without heart failure optimally treated after acute myocardial
infarction: a cohort study on the French healthcare databases. Circ Cardiovasc Qual
Outcomes. 2018;11(4):e004356. doi:10.1161/CIRCOUTCOMES.117.004356 - Lindenauer PK, Pekow P, Wang K, et al. Lipid-lowering therapy and in-hospital
mortality following major noncardiac surgery. JAMA. 2004;291(17):2092-2099.
doi:10.1001/jama.291.17.2092 - London MJ, Schwartz GG, Hur K, Henderson WG. Association of perioperative
statin use with mortality and morbidity after major noncardiac surgery. JAMA Intern
Med. 2017;177(2):231-242. doi:10.1001/jamainternmed.2016.8005 - Berwanger O, de Barros E Silva PG, Barbosa RR, et al. Atorvastatin for high-
risk statin-naïve patients undergoing noncardiac surgery. Am Heart J. 2017;184:88- - doi:10.1016/j.ahj.2016.11.001
- Graham MM, Sessler DI, Parlow JL, et al. Aspirin in patients with previous
percutaneous coronary intervention undergoing noncardiac surgery. Ann Intern Med.
2018;168(4):237-244. doi:10.7326/M17-2341 - Kobori T, Onishi Y, Yoshida Y, et al. Association of glucagon-like peptide-1
receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy.
J Diabetes Investig. 2023;14(6):767-773. doi:10.1111/jdi.14005 - Joshi GP, LaMasters T, Kindel TL. Preprocedure care of patients on glucagon-
like peptide-1 receptor agonists. Anesthesiology. 2024;141(6):1208-1209.
doi:10.1097/ALN.0000000000005231
